Action Aventis - AVE

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A NEW YORK, Oct. 15 /PRNewswire-FirstCall/ -- Rhone-Poulenc Overseas...

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers Pre-Booked Customers Received Partial or Full Influenza Vaccine Order in September; Balance to be Shipped in...

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease - First Candidate Quadrivalent Conjugate Meningococcal Vaccine - SWIFTWATER...

Aventis Named to List of Top 100 Companies for Working Mothers

Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Diseases WELLESLEY, Mass., Sept. 14 /PRNewswire/ -- Coley Pharmaceutical...

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer Earlier use of Taxotere(R) shown to significantly improve disease-free survival by reducing the risk of relapse...

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adolescents and Adults - Vaccine Leader Looks to Introduce Pertussis...

Ventiv Health Announces Sales and Marketing Agreement with Aventis

Ventiv Health Announces Sales and Marketing Agreement with Aventis Contract Calls for Over 450 Sales Representatives Focused on Primary Care and Specialist Markets SOMERSET, N.J., Aug. 5...

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid) BERWYN, Penn., Aug. 3 /PRNewswire/ -- Dermik Laboratories, the US dermatology arm of Aventis (NYSE:AVE), announced today that the US...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AVE - Frequently Asked Questions (FAQ)

What is the current Aventis share price?

The current share price of Aventis is US$ 0,00

What is the 1 year trading range for Aventis share price?

Aventis has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
BBAIBigBear ai Holdings Inc	US$ 7,1127 (44,86%)	269,64M
MWAMueller Water Products Inc	US$ 26,94 (16,72%)	5,66M
KOREKORE Group Holdings Inc	US$ 2,645 (15,50%)	44,84k
ERJEmbraer SA	US$ 45,7699 (14,86%)	3,51M
DNAGinkgo Bioworks Holdings Inc	US$ 16,37 (14,56%)	2,99M
FMCFMC Corp	US$ 35,93 (-33,51%)	25,34M
RXORXO Inc	US$ 21,49 (-14,92%)	3,66M
NYTNew York Times Co	US$ 49,23 (-11,92%)	5,55M
LICYLi Cycle Holdings Corp	US$ 0,8501 (-10,52%)	2,8M
CPRICapri Holdings Limited	US$ 21,605 (-10,09%)	13,64M
BBAIBigBear ai Holdings Inc	US$ 7,1127 (44,86%)	269,64M
FFord Motor Company	US$ 10,00 (-1,57%)	124,33M
SNAPSnap Inc	US$ 10,625 (-8,41%)	91,23M
QBTSD Wave Quantum Inc	US$ 6,265 (8,39%)	85,37M
UBERUber Technologies Inc	US$ 64,48 (-7,56%)	78,89M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AVE Dernières nouvelles

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Aventis Named to List of Top 100 Companies for Working Mothers

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Ventiv Health Announces Sales and Marketing Agreement with Aventis

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

AVE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE) Cours

Aventis New Ads (AVE)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AVE Dernières nouvelles

AVE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE